Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

Parkinson’s disease

Doxycycline shows promise as repurposed drug against Parkinson’s disease

Antibiotic used against bacterial infections found to target formation of molecular trigger of inflammation in Parkinson’s disease.

Repurposing drugs that have already been tested for safety against novel targets has become an attractive strategy for researchers trying to find cures for progressive neurodegenerative disorders such as Parkinson’s disease (PD).

Doxycycline is a tetracycline antibiotic used to treat many types of bacterial infection and has been shown to prevent neurodegeneration in PD models. However, a study published in Scientific Reports[1] (3 February 2017) found that doxycycline was also able to reduce the toxicity of α-synuclein, which aggregates to form amyloid fibrils — the molecular trigger of inflammation in PD.

The researchers found that a low dose of doxycycline reduced aggregation of α-synuclein by more than 80% and caused it to reform as an oligomer which does not form fibrils and is non-toxic for human neuroblastoma cells in culture.

The study concludes that the results reveal the potential protective side effects for low-dose doxycycline in the formation of α–synuclein that could be exploited against PD.

Citation: Clinical Pharmacist DOI: 10.1211/CP.2017.20202774

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • FASTtrack: Pharmacology

    FASTtrack: Pharmacology

    FASTtrack: Pharmacology is a study guide providing an account of drug action, as well as dealing with molecular pharmacology at a more advanced level.

    £24.00Buy now
  • Drugs and the Liver

    Drugs and the Liver

    Drugs and the Liver assists practitioners in making pragmatic choices for their patients. It enables you to assess liver function and covers the principles of drug use in liver disease.

    £37.00Buy now
  • FASTtrack: Pharmaceutics - Drug Delivery and Targeting

    FASTtrack: Pharmaceutics - Drug Delivery and Targeting

    Pharmaceutics: Drug Delivery and Targeting systematically reviews important concepts for drug delivery systems and targeting of drugs.

    £24.00Buy now
  • Introduction to Renal Therapeutics

    Introduction to Renal Therapeutics

    Introduction to Renal Therapeutics covers all aspects of drug use in renal failure. Shows the role of the pharmacist in patient care for chronic kidney disease.

    £37.00Buy now
  • Martindale: The Complete Drug Reference

    Martindale: The Complete Drug Reference

    Martindale: The Complete Drug Reference provides reliable, unbiased and evaluated information on drugs and medicines used throughout the world.

    £550.00Buy now
  • Disease Management

    Disease Management

    Disease Management covers the diseases commonly encountered in primary care by system, with common therapeutic issues. Includes case studies and self-assessment sections.

    £52.00Buy now

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • Molecular structure of doxycycline

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.